Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.72 - $14.77 $11,440 - $29,540
2,000 New
2,000 $16,000
Q4 2023

Feb 14, 2024

SELL
$1.82 - $3.16 $25,298 - $43,924
-13,900 Reduced 98.58%
200 $0
Q3 2023

Nov 14, 2023

BUY
$3.17 - $7.91 $4,755 - $11,865
1,500 Added 11.9%
14,100 $47,000
Q2 2023

Aug 14, 2023

BUY
$7.35 - $13.21 $92,610 - $166,446
12,600 New
12,600 $92,000
Q3 2022

Nov 14, 2022

BUY
$20.09 - $35.8 $367,647 - $655,140
18,300 New
18,300 $384,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $414M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.